Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2022 Feb:241:126-132.e3.
doi: 10.1016/j.jpeds.2021.09.029. Epub 2021 Sep 25.

Dynamics of Reverse Transcription-Polymerase Chain Reaction and Serologic Test Results in Children with SARS-CoV-2 Infection

Affiliations
Clinical Trial

Dynamics of Reverse Transcription-Polymerase Chain Reaction and Serologic Test Results in Children with SARS-CoV-2 Infection

Alfredo Tagarro et al. J Pediatr. 2022 Feb.

Abstract

Objectives: To determine the time to reverse transcription-polymerase chain reaction (RT-PCR) negativity after the first positive RT-PCR test, factors associated with longer time to RT-PCR negativity, proportion of children seroconverting after proven severe acute respiratory syndrome coronavirus 2 infection, and factors associated with the lack of seroconversion.

Study design: The Epidemiological Study of Coronavirus in Children of the Spanish Society of Pediatrics is a multicenter study conducted in Spanish children to assess the characteristics of coronavirus disease 2019. In a subset of patients, 3 serial RT-PCR tests on nasopharyngeal swab specimens were performed after the first RT-PCR test, and immunoglobulin G serology for severe acute respiratory syndrome coronavirus 2 antibodies was performed in the acute and follow-up (<14 and ≥14 days after diagnosis) phase.

Results: In total, 324 patients were included in the study. The median time to RT-PCR negativity was 17 days (IQR, 8-29 days), and 35% of patients remained positive more than 4 weeks after the first RT-PCR test. The probability of RT-PCR negativity did not differ across groups defined by sex, disease severity, immunosuppressive drugs, or clinical phenotype. Globally, 24% of children failed to seroconvert after infection. Seroconversion was associated with hospitalization, persistence of RT-PCR positivity, and days of fever.

Conclusions: Time to RT-PCR negativity was long, regardless of the severity of symptoms or other patient features. This finding should be considered when interpreting RT-PCR results in a child with symptoms, especially those with mild symptoms. Seroprevalence and postimmunization studies should consider that 11 in 4 infected children fail to seroconvert.

Keywords: COVID-19; RT-PCR; SARS-CoV-2; children; dynamics; seroconversion; serology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A, Ct over time. The line represents an inference of the trajectory of Cts until negativity. Negative values are presented as a Ct of 45. Negative values beyond 60 days are not presented. B, Box-and-whiskers distributions of Ct across weeks. Most of the samples had a high Ct value. At diagnosis, the median Ct was 38.5 (IQR, 35.5-40.0).
Figure 3
Figure 3
Flowchart of patients with serologic follow-up. Overall, at least 22/93 (23.6%) children with a recent RT-PCR positive test and available serum specimens did not develop detectable IgG SARS-CoV-2 antibodies. N/A, not applicable.
Figure 4
Figure 4
Probability of RT-PCR test negativity in all 324 participants.
Figure 2
Figure 2
Probability of RT-PCR negativity by A, severity, B, immunosuppressive medication or C, phenotype. PICU, pediatric intensive care unit; URTI, upper respiratory tract infection.

Similar articles

Cited by

References

    1. Han M.S., Choi E.H., Chang S.H., Jin B.-L., Lee E.J., Kim B.N., et al. Clinical characteristics and viral RNA detection in children with coronavirus disease 2019 in the Republic of Korea. JAMA Pediatr. 2021;175:73. - PMC - PubMed
    1. Long Q.-X., Tang X.-J., Shi Q.-L., Li Q., Deng H.-J., Yuan J., et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200–1204. - PubMed
    1. Moraleda C., Serna-Pascual M., Soriano-Arandes A., Simó S., Epalza C., Santos M., et al. Multi-inflammatory syndrome in children related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Spain. Clin Infect Dis. 2021;72:e397–e401. - PMC - PubMed
    1. Wang H., Ai J., Loeffelholz M.J., Tang Y.-W., Zhang W. Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals. Emerg Microbes Infect. 2020;9:2200–2211. - PMC - PubMed
    1. Cento V., Colagrossi L., Nava A., Lamberti A., Senatore S., Travi G., et al. Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients. J Infect. 2020;81:e90–e92. - PMC - PubMed

Publication types

MeSH terms